Literature DB >> 7781771

Ecotin is a potent inhibitor of the contact system proteases factor XIIa and plasma kallikrein.

J S Ulmer1, R N Lindquist, M S Dennis, R A Lazarus.   

Abstract

Ecotin, a serine protease inhibitor found in the periplasm of Escherichia coli, has been characterized as a potent reversible tight-binding inhibitor of the human contact activation proteases factor XIIa (FXIIa) and plasma kallikrein, having Ki values of 89 pM and 163 pM, respectively. Ecotin also inhibited human leukocyte elastase (HLE) with high affinity (Ki = 55 pM). The association rate constants kon for FXIIa and kallikrein were 5.3 x 10(5) M-1.s-1 and 2.9 x 10(5) M-1.s-1, respectively. The dissociation rate constant koff for kallikrein, measured in the presence of HLE to prevent reassociation, was 6.3 x 10(-5) s-1; the koff for ecotin with FXIIa was 4.7 x 10(-5) s-1. Both FXIIa and kallikrein cleaved ecotin slowly at pH 5.0, identifying Met-84 as the P1 residue. The potent anticoagulant effect by ecotin is explained by the coincident inhibition of FXIIa, kallikrein, and FXa and suggests that it may be useful in the study of inflammatory or thrombotic disorders such as sepsis or cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781771     DOI: 10.1016/0014-5793(95)00466-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Crystal structure analyses of uncomplexed ecotin in two crystal forms: implications for its function and stability.

Authors:  D H Shin; H K Song; I S Seong; C S Lee; C H Chung; S W Suh
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

Review 2.  Factor XI and XII as antithrombotic targets.

Authors:  Felicitas Müller; David Gailani; Thomas Renné
Journal:  Curr Opin Hematol       Date:  2011-09       Impact factor: 3.284

3.  A culture-based method for determining the production of secreted protease inhibitors.

Authors:  David Quintero; David Bermudes
Journal:  J Microbiol Methods       Date:  2014-03-12       Impact factor: 2.363

4.  A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation.

Authors:  S Selvarajan; L R Lund; T Takeuchi; C S Craik; Z Werb
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

5.  Potential Anticoagulant Activity of Trypsin Inhibitor Purified from an Isolated Marine Bacterium Oceanimonas Sp. BPMS22 and its Kinetics.

Authors:  B S Harish; Kiran Babu Uppuluri
Journal:  Mar Biotechnol (NY)       Date:  2018-08-18       Impact factor: 3.619

Review 6.  Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.

Authors:  Tomasz Kantyka; Neil D Rawlings; Jan Potempa
Journal:  Biochimie       Date:  2010-06-14       Impact factor: 4.079

7.  COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke.

Authors:  Peter Kraft; Tobias Schwarz; Lionel Pochet; Guido Stoll; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2010-02-15

8.  The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase.

Authors:  Christopher T Eggers; Iain A Murray; Valerie A Delmar; Anthony G Day; Charles S Craik
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

9.  Molecular recognition of chymotrypsin by the serine protease inhibitor ecotin from Yersinia pestis.

Authors:  Elizabeth A Clark; Nicola Walker; Donna C Ford; Ian A Cooper; Petra C F Oyston; K Ravi Acharya
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

10.  Rickettsia phylogenomics: unwinding the intricacies of obligate intracellular life.

Authors:  Joseph J Gillespie; Kelly Williams; Maulik Shukla; Eric E Snyder; Eric K Nordberg; Shane M Ceraul; Chitti Dharmanolla; Daphne Rainey; Jeetendra Soneja; Joshua M Shallom; Nataraj Dongre Vishnubhat; Rebecca Wattam; Anjan Purkayastha; Michael Czar; Oswald Crasta; Joao C Setubal; Abdu F Azad; Bruno S Sobral
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.